Haemonetics (HAE) Tops Q3 EPS by 3c; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $77.29 -0.43%
Revenue Growth %: +2.3%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +2.3%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $305.3 million versus the consensus estimate of $299.08 million.
GUIDANCE:
Haemonetics sees FY2023 EPS of $2.90-$3.00, versus the consensus of $2.92.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- BTIG Reiterates Buy Rating on Haemonetics (HAE)
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
